Number and proportion of treatment regimens prescribed for a cohort of US hospital-based laboratory-confirmed Mycobacterium avium complex patients, by provider- and facility-level factors, among those encounters receiving treatment

Subjects

Guidelines based

Resistance associated

Other

Size of facility (number of beds)

<200

118

18 (15)

42 (36)

58 (49)

200–499

434

74 (17)

144 (33)

216 (50)

≥500

286

60 (21)

60 (21)#,¶

166 (58)¶

Teaching status

Yes

480

87 (18)

149 (31)

244 (51)

No

358

65 (18)

97 (27)

196 (55)

Setting of facility

Rural

44

10 (23)

8 (18)

26 (59)

Urban

794

142 (18)

238 (30)

414 (52)

Region of facility

Midwest

185

20 (11)

53 (29)

112 (61)

Northeast

224

30 (13)

94 (42)#

100 (45)#

South

295

70 (24)#,¶

70 (24)¶

155 (53)

West

134

32 (24)#,¶

26 (22)¶

73 (54)

Specialty of attending physician

Internal medicine

326

71 (22)

93 (29)

162 (50)

Pulmonology

78

15 (19)

19 (24)

44 (56)

Hospitalists

208

29 (14)#

70 (34)

109 (52)

Other

226

37 (16)

64 (28)

125 (55)

Data are presented as n or n (%). Significance p≤0.05. #: significantly different from category 1; ¶: significantly different from category 2.

TABLE 5

Hospital encounters where treatment regimen was prescribed by comorbidity for laboratory-confirmed Mycobacterium avium complex cases, among encounters where treatment was received